Advertisement

Behandlung der rezidivierenden oralen Aphthen und des Morbus Behçet

  • E. Haneke
Conference paper
Part of the Verhandlungen der Deutschen Dermatologischen Gesellschaft book series (VDGDERMATOLOGIE, volume 32)

Zusammenfassung

Da es eine einheitliche Ursache der Aphthen- und Behçet-Krankheit wahrscheinlich nicht gibt, ist eine kausale Behandlung meist nicht möglich. In Abhängigkeit von der Schwere der Erkrankung, vom subjektiven Krankheitsgefühl und von der Prognose der verschiedenen oralen Aphthosen ist eine örtliche und/oder Allgemeinbehandlung erforderlich, deren Risiko in einem vernünftigen Verhältnis zur Schwere der Erkrankung stehen soll.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bishop PMF, Harris PWR, Trafford JAP (1967) Oestrogen treatment of recurrent aphthous mouth ulcers. Lancet 1: 1345–1347PubMedCrossRefGoogle Scholar
  2. 2.
    Carruthers R (1967) Oral ulcers. Aust Dent J 12: 179CrossRefGoogle Scholar
  3. 3.
    Cohen L (1978) Etiology, pathogenesis and classification of aphthous stomatitis and Behçet’s syndrome. J Oral Pathol 7: 347–352PubMedCrossRefGoogle Scholar
  4. 4.
    Cooke BED (1979) Oral ulceration in Behçet’s syndrome: In: Lehner T, Barnes CG (eds) Behçet’s syndrome. Clinical and immunological features. Academic Press, London, pp 143–149Google Scholar
  5. 5.
    Cunliffe WJ (1979) Fibrolytic agents (Abstract). Multidisciplinary Symposium on Behçet’s Syndrome, London, 20. 2. 1979Google Scholar
  6. 6.
    Denman AM, Fialkow PJ, Pelton BK, Salo AC, Appleford DJ (1979) Attempts to establish a viral aetiology for Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Behçet’s syndrome. Clinical and immunological features. Academic Press, London, pp 91–105Google Scholar
  7. 7.
    Dunlop EMC (1979) Genital and other manifestations of Behçet’s disease seen in venerological practice. In: Lehner T, Barnes CG (eds) Behçet’s syndrome. Clinical and immunological features. Academic Press, London pp 159–175Google Scholar
  8. 8.
    Ferguson R, Bosn MK, Asquith P, Cooke WT (1976) Jejuna] mucosal abnormalities in patients with recurrent aphthous ulceration. Br Med J 1: 11–13PubMedCrossRefGoogle Scholar
  9. 9.
    Fischer N (1979) Bextasol and aphthous ulcers. Br Med J 1: 1357CrossRefGoogle Scholar
  10. 10.
    Fraser-Moodie W (1960) The treatment of aphthous ulceration with gamma globulin: The results obtained in a controlled series. Br Dent J 108: 326–328Google Scholar
  11. 11.
    Graykowski EA, Kingman A (1978) Double blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 7: 376–382PubMedCrossRefGoogle Scholar
  12. 12.
    Graykowski EA, Barile MF, Lee WB, Stanley HR (1966) Recurrent aphthous stomatitis. JAMA 196: 637–644PubMedCrossRefGoogle Scholar
  13. 13.
    Gilder A, Tat AL (1979) A treatment trial on Behçet’s syndrome with Sabin (polio) vaccine. In: Dillen N, Koniçe M, Övül C (eds) Behçet’s disease. Excerpta Medica, Amsterdam Oxford, pp 305–306Google Scholar
  14. 14.
    Haim S, Sherf K (1966) Behçet’s disease. Presentation of 11 patients and evaluation of treatment. Jsr J Med Sci 2: 269Google Scholar
  15. 15.
    Haneke E (1979) Levamisol-Therapie bei verschiedenen dermatologischen Indikationen. Z Hautkr 54: 408–414PubMedGoogle Scholar
  16. 16.
    Honma T (1976) Electronmicroscopic study on the pathogenesis of recurrent aphthous ulceration as compared to Behçet’s syndrome. Oral Surg 41: 366–377PubMedCrossRefGoogle Scholar
  17. 17.
    Hori Y, Miyazawa S, Nishiyama S, Miyata M, Ishikawa S (1979) Experimental Behçet’s disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol (Tokyo) 6: 31–37Google Scholar
  18. 18.
    Hornstein OP (1979) Orale Aphthen — örtliche and allgemeinmedizinische Aspekte. Dtsch Zahnaerztl Z 34: 808–817PubMedGoogle Scholar
  19. 19.
    Kaplan B, Cardarelli C, Pinnell SR (1978) Double-blind study of levamisole in aphthous stomatitis. J Oral Pathol 7: 400–404PubMedCrossRefGoogle Scholar
  20. 20.
    Lehner T, Wilton JMA (1979) The therapeutic and immunological effects of levamisole in recurrent oral ulcers and Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Behçet’s syndrome. Clinical and immunological features. Academic Press, London pp 291–305Google Scholar
  21. 21.
    Lessof MH, Jefferys DB, Lehner T, Maltock M, Sanders MD (1979) Corticosteroids and azathioprine; their use in Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Behçet’s syndrome. Clinical and immunological features. Academic Press, London pp 267–275Google Scholar
  22. 22.
    Matsumura N, Nizushima Y (1975) Leucocyte movement and colchicine in Behçet’s disease. Lancet 2: 813PubMedCrossRefGoogle Scholar
  23. 23.
    Mineshita S, Ogino T, Shimizu T (1979) Zinc therapy in Behçet’s disease. In: Dillen N, Koniçe M, Övül C (eds) Behçet’s disease. Excerpta Medica, Amsterdam Oxford, pp 301–304Google Scholar
  24. 24.
    Symoens J (1979) Immunpharmakologie des Levamisol. Z Hautkr 54: 394–402PubMedGoogle Scholar
  25. 25.
    Verhaegen H, DeCree J, Brugmans J (1973) Treatment of aphthous stomatitis. Lancet 2: 542Google Scholar
  26. 26.
    Woodburne AR (1941) Herpetic stomatitis (aphthous stomatitis). Arch Dermatol Syph (Bol) 43: 543–547CrossRefGoogle Scholar
  27. 27.
    Wray D, Ferguson MM, Hucheon AW, Dagg JH (1978) Nutritional deficiencies in recurrent aphthae. J Oral Pathol 7: 418–423PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • E. Haneke
    • 1
  1. 1.ErlangenDeutschland

Personalised recommendations